February, 2024
February 2024
M T W T F S S
 1234
567891011
12131415161718
19202122232425
26272829  
Earle Burgess: Initial results from a small pilot study in late mCRPC where there are limited to no effective treatment options available
Jan 31, 2024, 17:49

Earle Burgess: Initial results from a small pilot study in late mCRPC where there are limited to no effective treatment options available

Earle Burgess, Genitourinary Oncologist at Atrium Health Levine Cancer, shared on LinkedIn:

Enfortumab vedotin is a blockbuster drug in bladder cancer.
Looks like it might have activity in prostate cancer as well.

Initial results from a small pilot study in late mCRPC where there are limited to no effective treatment options available.

Large unmet need in this setting, so this could be a big deal if confirmed.”

Read Further.
Source: Earle Burgess/LinkedIn